Why it was recalled
Defective Delivery System: difficult to express
Product description
BEVACIZUMAB 1.25 mg/0.05 mL 31G MJ syringe Intravitreal Injection. This biologic product was repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne, FL 32901 Lot:190212AB BUD:5/13/2019, Repackaged on 2/12/2019
Lot numbers, UPCs & expiration codes
Lot: 190212AB BUD: 5/13/2019
Where it was sold
Nationwide in the US
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-1271-2019
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Apr 19, 2019
- FDA report date
- May 8, 2019
- Quantity
- 249 syringes
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Pacifico National, Inc. dba AmEx Pharmacy
Original FDA data
Every field from FDA enforcement report D-1271-2019, exactly as published.
Show all FDA fields
- City
- Melbourne
- State
- FL
- Status
- Terminated
- Country
- United States
- Event ID
- 82676
- Address
- 1515 Elizabeth St Ste J
- Code information
- Lot: 190212AB BUD: 5/13/2019
- Postal code
- 32901-3000
- Report date
- May 8, 2019
- Product type
- Drugs
- Recall number
- D-1271-2019
- Classification
- Class II
- Recalling firm
- Pacifico National, Inc. dba AmEx Pharmacy
- Product quantity
- 249 syringes
- Termination date
- Feb 16, 2021
- Reason for recall
- Defective Delivery System: difficult to express
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- BEVACIZUMAB 1.25 mg/0.05 mL 31G MJ syringe Intravitreal Injection. This biologic product was repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne, FL 32901 Lot:190212AB BUD:5/13/2019, Repackaged on 2/12/2019
- Distribution pattern
- Nationwide in the US
- Recall initiation date
- Apr 19, 2019
- Initial firm notification
- Telephone
- Center classification date
- May 7, 2019